View Our Latest Perspectives
Innovative ideas and insightsRead More
Rafe Hanahan co-leads Cain Brothers’ Medical Technologies Advisory practice. Mr. Hanahan joined Cain Brothers in 2015 and has 17 years’ experience advising both public and private companies in a variety of merger and acquisition, capital raising, and strategic advisory transactions. Mr. Hanahan’s notable transactions include the sale of ClearCorrect LLC to the Straumann Group; the sale of Collagen Matrix to MetalMark Capital; the take-private transaction of Kinetic Concepts; bond offerings for Abbott, Biomet, Boston Scientific, C.R. Bard, DJO Global, and Zimmer, and equity offerings for Endocyte, Integra LifeSciences, LDR Spine, and TransEnterix, among others.
Prior to joining Cain Brothers, Mr. Hanahan covered medical technology and devices at RBC Capital Markets. Prior to RBC, Mr. Hanahan was at Trivest Partners, a middle-market private equity firm, and at Bear Stearns in that firm’s Global Healthcare Group.
Mr. Hanahan graduated from the Lundquist College of Business at the University of Oregon (Finance) and received an M.B.A from the Goizueta Business School at Emory University (Finance & Leadership).